Abstract
Introduction: Lung cancer has the highest mortality rate among all cancers in both men and women. Aerosol delivery is a noninvasive method for gene delivery to the lungs, although efficient and biocompatible vectors need to be developed for lung cancer therapy.
Areas covered: This review summarizes recent advances in airway gene delivery for lung cancer treatment in animal models using viral vectors or cationic polymers. Viral vectors including lentiviruses and adenoviruses have been used for airway gene delivery because of their high transfection efficiency. Cationic polymers have also been developed for aerosol gene therapy owing to their biocompatibility and ease of modification.
Expert opinion: Efficient delivery and specific promoters are needed for lung cancer therapy. Capsid engineering or PEGylation can lower immunogenicity. Moreover, immunotherapy and oncolytic viruses need to be tested with aerosol delivery for lung cancer therapy. Meanwhile, naturally existing cationic materials may allow the development of novel and biocompatible carriers. In combination with various technologies for aerosol delivery, novel and specific carriers could be developed for lung cancer therapy in the future. Finally, standardized protocols for quantifying and manufacturing viral vectors and cationic polymers need to be developed in order to ensure biosafety.
Acknowledgments
S-H Hong and S-J Park contributed equally to this work. This work was supported by National Research Foundation grant (2012M3A9B6055304) funded by the Ministry of Science, ICT & Future Planning.
Declaration of interest
The authors have no relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript. This includes employment, consultancies, honoraria, stock ownership or options, expert testimony, grants or patents received or pending, or royalties.
Notes
This box summarizes key points contained in the article.
Hwang SK, Lim HT, Minai-Tehrani A, et al. Repeated aerosol delivery of carboxyl-terminal modulator protein suppresses tumor in the lungs of K-rasLA1 mice. Am J Respir Crit Care Med 2009;179:1131-40 Shin JY, Hong SH, Kang B, et al. Overexpression of beclin1 induced autophagy and apoptosis in lungs of K-rasLA1 mice. Lung cancer 2013;81:362-70 Yu KN, Minai-Tehrani A, Chang SH, et al. Aerosol delivery of small hairpin osteopontin blocks pulmonary metastasis of breast cancer in mice. PLoS One 2010;5:e15623 Chang SH, Kim JE, et al. Aerosol delivery of eukaryotic translation initiation factor 4E-binding protein 1 effectively suppresses lung tumorigenesis in K-rasLA1 mice. Cancer Gene Ther 2013;20:331-5 Hwang SK, Piao L, Lim HT, et al. Suppression of lung tumorigenesis by leucine zipper/EF hand–containing transmembrane-1. PLoS One 2010;5:e12535 Park MR, Han KO, Han IK, et al. Degradable polyethylenimine-alt-poly (ethylene glycol) copolymers as novel gene carriers. J Control Release 2005;105:367-80 Xu CX, Jere D, Jin H, et al. Poly (ester amine)-mediated, aerosol-delivered Akt1 small interfering RNA suppresses lung tumorigenesis. Am J Respir Crit Care Med 2008;178:60-73 Jiang HL, Xu CX, Kim YK, et al. The suppression of lung tumorigenesis by aerosol-delivered folate-chitosan-graft-polyethylenimine/Akt1 shRNA complexes through the Akt signaling pathway. Biomaterials 2009;30:5844-52 Kim TH, Ihm JE, Choi YJ, et al. Efficient gene delivery by urocanic acid-modified chitosan. J Control Release 2003;93:389-402 Jin H, Xu CX, Kim HW, et al. Urocanic acid-modified chitosan-mediated PTEN delivery via aerosol suppressed lung tumorigenesis in K-ras(LA1) mice. Cancer Gene Ther 2008;15:275-83 Jiang HL, Hong SH, Kim YK, et al. Aerosol delivery of spermine-based poly(amino ester)/Akt1 shRNA complexes for lung cancer gene therapy. Int J Pharm 2011;420:256-65 Chang SH, Hong SH, Jiang HL, et al. GOLGA2/GM130, cis-Golgi matrix protein, is a novel target of anticancer gene therapy. Mol Ther 2012;20:2052-63 Hong SH, Kim JE, Kim YK, et al. Suppression of lung cancer progression by biocompatible glycerol triacrylate-spermine-mediated delivery of shAkt1. Int J Nanomedicine 2012;7:2293-306